Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2011

01-08-2011 | Editor's Page

Imaging of vulnerable plaques: Will it affect patient management and influence outcomes?

Author: George A. Beller, MD

Published in: Journal of Nuclear Cardiology | Issue 4/2011

Login to get access

Excerpt

Significant advances have been made in the ability to image atherosclerotic plaques in multiple vascular beds in both animal models and in patients.1 Imaging of atherosclerosis in asymptomatic adults by identifying presence of coronary artery calcification (CAC) in plaques with CT scanning is already an accepted technology that received a Class IIa recommendation in the guidelines published by the American College of Cardiology and the American Heart Association.2 Evidence from a large number of subjects shows that the greater the extent of CAC, the higher the future cardiac event rate.3 Those subjects with a zero CAC score have an excellent outcome out to 10-12 years after imaging.4 The EISNER Trial showed that patients who are given results of their CAC score are more likely to modify their CAD risk factors and lower their LDL-cholesterol and blood pressure to a greater degree than patients randomized to a “No Scan” strategy.5 Coronary CT angiography (CCTA) can not only identify flow limiting coronary artery stenoses but also detect plaques with characteristics of vulnerability that are associated with an increase risk of acute coronary syndromes.1,6 These features include positive vessel remodeling, low attenuation plaques (<30 HU) and spotty calcification. …
Literature
1.
go back to reference Vancraeynest D, Passquet A, Roelants V, Gerber BL, Vanoverschelde J-L. Imaging the vulnerable plaque. J Am Coll Cardiol 2011;57:1961-79.PubMedCrossRef Vancraeynest D, Passquet A, Roelants V, Gerber BL, Vanoverschelde J-L. Imaging the vulnerable plaque. J Am Coll Cardiol 2011;57:1961-79.PubMedCrossRef
2.
go back to reference Greenland P, Alpert JS, Beller GA, Benjamin EF, Budoff MJ, Fayad ZA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:2182-99.CrossRef Greenland P, Alpert JS, Beller GA, Benjamin EF, Budoff MJ, Fayad ZA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:2182-99.CrossRef
3.
go back to reference Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: Observations from a registry of 25, 253 patients. J Am Coll Cardiol 2007;49:1860-70.PubMedCrossRef Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: Observations from a registry of 25, 253 patients. J Am Coll Cardiol 2007;49:1860-70.PubMedCrossRef
4.
go back to reference Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. J Am Coll Cardiol Imaging 2009;2:692-700. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. J Am Coll Cardiol Imaging 2009;2:692-700.
5.
go back to reference Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Oeats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 2011;57:000.CrossRef Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Oeats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 2011;57:000.CrossRef
6.
go back to reference Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.PubMedCrossRef Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.PubMedCrossRef
7.
go back to reference Mauriello A, Sangiorgi G, Fratoni S, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: A histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005;45:1585-93.PubMedCrossRef Mauriello A, Sangiorgi G, Fratoni S, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: A histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005;45:1585-93.PubMedCrossRef
8.
go back to reference Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina. J Am Coll Cardiol Imaging 2010;3:388-97. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina. J Am Coll Cardiol Imaging 2010;3:388-97.
9.
go back to reference Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med 2004;45:1898-907.PubMed Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med 2004;45:1898-907.PubMed
10.
go back to reference Tahara N, Kai H, Yamagishi S, et al. Vascular inflammation evaluated by F-18-flurodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007;49:1533-9.PubMedCrossRef Tahara N, Kai H, Yamagishi S, et al. Vascular inflammation evaluated by F-18-flurodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007;49:1533-9.PubMedCrossRef
11.
go back to reference Lee SJ, On YK, Lee EJ, et al. Reversal of vascular 18-FDG with plasma high density lipoprotein elevation by atherogenic risk reduction. J Nucl Med 2008;49:1277-82.PubMedCrossRef Lee SJ, On YK, Lee EJ, et al. Reversal of vascular 18-FDG with plasma high density lipoprotein elevation by atherogenic risk reduction. J Nucl Med 2008;49:1277-82.PubMedCrossRef
12.
go back to reference Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation. Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825-31.PubMedCrossRef Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation. Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825-31.PubMedCrossRef
13.
go back to reference Tang TY, Howarth SP, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophages Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009;53:2039-50.PubMedCrossRef Tang TY, Howarth SP, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophages Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009;53:2039-50.PubMedCrossRef
14.
go back to reference Rudd JHF, Narula J, Strauss HW, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: Ready for prime time? J Am Coll Cardiol 2010;55:2527-35.PubMedCrossRef Rudd JHF, Narula J, Strauss HW, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: Ready for prime time? J Am Coll Cardiol 2010;55:2527-35.PubMedCrossRef
Metadata
Title
Imaging of vulnerable plaques: Will it affect patient management and influence outcomes?
Author
George A. Beller, MD
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 4/2011
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-011-9412-x

Other articles of this Issue 4/2011

Journal of Nuclear Cardiology 4/2011 Go to the issue